DUBLIN, Jan. 13, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation related to Dupuytren's contracture (DC) and XIAFLEX® (collagenase clostridium histolyticum, or ...
PALO ALTO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel ...
Keenova Therapeutics plc announced the first-time publication of a retrospective analysis using previously generated XIAFLEX® (collagenase clostridium histolyticum) data. The analysis evaluates ...
For patients with moderate Dupuytren contracture, collagenase injection is not noninferior to limited fasciectomy, according to a study published online Oct. 9 in the New England Journal of Medicine.
For patients with moderate Dupuytren contracture, collagenase injection is not noninferior to limited fasciectomy, according to a study published online Oct. 9 in the New England Journal of Medicine.
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results